Tobacco Giant Philip Morris to Buy Israeli Cannabis Company

The deal is expected to proceed in stages and is dependent on completion of clinical trials in the U.S.

Tobacco titan Philip Morris International Inc. (NYSE: PM), the maker of Marlboro cigarettes, is poised to spend up to $650 million on an Israeli cannabis company that specializes in metered-dose inhalers for pain management.

According to the Israeli publication Calcalist, the deal will proceed in stages, with the first being a $120 million investment by Philip Morris in Syqe Medical, which it already backed with a $20 million investment in 2016.

If that money is enough to get Syqe through clinical trials and the company gets approval from the U.S. Food and Drug Administration, Philip Morris has committed to purchasing all of the company’s shares for $650 million, Calcalist reported.

The deal will be solidified by Philip Morris subsidiary Vectura, and if the acquisition closes, it’s expected to transform Syqe into one of the largest marijuana companies in the world.

Syqe inhalers are so far available only in Australia and Israel. The product was approved in Canada two years ago but appears not to have made it to market, MJBizDaily reported.

The move is an unsurprising one for Philip Morris, given that the company has said for years that it’s been analyzing business opportunities in the marijuana space.

It’s also nowhere near the first large tobacco company to explore cannabis options. Altria Group Inc. (NYSE: MO) dove into marijuana in 2018 with a $1.8 billion investment into Canadian company Cronos Group, and British tobacco company Imperial Brands invested $93.4 million in Auxly Cannabis Group, another Canadian business.

John Schroyer

John Schroyer has been a reporter since 2006, initially with a focus on politics, and covered the 2012 Colorado campaign to legalize marijuana. He has written about the cannabis industry specifically since 2014, after being on hand for the first-ever legal cannabis sales on New Year’s Day that year in Denver. John has covered subsequent marijuana market launches in California and Illinois, has written about every aspect of the marijuana trade, and was part of the team that built the cannabis industry’s first-ever trade show, MJBizCon. He joined Green Market Report in 2022.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.